Introduction
Modern medical practice involves the use of an increasingly broad array of implantable and blood contact devices. Many of the polymers that form the base materials of these devices were not designed to marry with the host environment but were commercially available materials pressed into service as needed. Unfortunately, almost all of these polymers, such as polyurethanes, silicone elastomers, and polyethylene terephthalate (e.g., Dacron®), trigger, to varying degrees, undesirable host responses including coagulation, inflammation, and fibrosis (1) (2) (3) (4) (5) (6) (7) (8) . These host responses can in turn lead to the degradation and/or failure of biomedical devices (see, e.g., ref. 9) , sometimes with fatal consequences.
Inflammatory and fibrotic responses are also typical of so-called foreign-body reactions triggered by implants acquired by misadventure, such as bullets and splinters. It is fair to say that we still do not completely understand the pathophysiologic mechanisms by which foreign materials-purposefully or accidentally intruded into the body-initiate and propagate inflammation and fibrosis. These reactions are most puzzling in the case of biomaterials that generally lack leachable toxins, are nonimmunogenic, and are chemically inert. This leads to the rather obvious question of how the host first detects and then mounts an inflammatory response to these apparently innocuous biomedical materials.
The surfaces of most commonly used biomaterials spontaneously adsorb a layer of host protein within seconds to minutes after tissue or blood contact (10, 11) . Probably as a result of the hydrophobic surface properties of these materials, adsorbed proteins progressively change conformation, becoming denatured and impossible to remove with detergents such as sodium dodecyl sulfate (12) (13) (14) (15) (16) . These primary protein-surface interactions typically precede the arrival of host inflammatory cells at implant surfaces. Therefore, inflammatory responses are probably influenced, if not dictated, by this spontaneously acquired chaotic layer of host protein and it is believed that the types of adsorbed proteins comprising this layer are critical determinants of biocompatibility (16, 17) . Working from this assumption, we set about to determine those host protein(s) of greatest importance in ensuing inflammatory responses to experimental implants. To do this, we employed an animal model in which test specimens (of polyethylene terephthalate film) were implanted intraperitoneally in mice, in some cases after being coated with various proteins (12, 18) . The extent of acute inflammatory response was monitored by measuring the numbers of neutrophils (PMN) and monocytes/macrophages (MO) adherent to the test specimens 16-24 hr after implantation.
Albumin, fibrinogen, immunoglobulin G (IgG) and complement components are usually the most abundant spontaneously adsorbed proteins on the surfaces of polymeric biomaterials (17, 19, 20) . Adsorbed albumin probably can be ruled out as causal of subsequent inflammatory responses because biomaterials precoated with purified albumin are "passivated" and attract few phagocytic cells (11, (21) (22) (23) (24) . Furthermore, although many earlier studies have shown that adsorbed IgG and complement activation caused by biomaterial surfaces will activate phagocytes (25) (26) (27) (28) , both IgG-deficient (severe combined immunodeficient) mice and complement-depleted (cobra venom factor-treated) mice exhibit "normal" inflammatory responses to implanted biomaterials (18) . Therefore, neither spontaneous IgG adsorption nor surface-initiated complement activation is critical in the recruitment of inflammatory cells to biomaterial implants (18) .
Instead, and rather unexpectedly, surfacebound fibrinogen appears to be essential for the genesis of inflammatory responses to implanted biomaterials (12) . There are three lines of evidence for this. First, experimental implants precoated with serum, which is almost completely lacking in fibrinogen, fail to accumulate phagocytes whereas those coated with plasma do (to the same extent as seen following implantation of uncoated material). Importantly, implants precoated with fibrinogen-reconstituted serum engender "normal" inflammatory responses. Second, by the same token, implants precoated with afibrinogenemic plasma are passivated, but those coated with fibrinogen-reconstituted afibrinogenemic plasma cause inflammatory cell recruitment. Finally, mice pretreated with ancrod (and thereby depleted of almost all detectable fibrinogen) fail to mount an inflammatory response to uncoated implants but do so if the material is preincubated with either plasma or purified fibrinogen (12 (44) . Phagocyte Adherence to Biomaterial Implants As indicated above, certain fibrin(ogen) epitopes, particularly P1, are known to interact with the phagocyte Mac-I integrin (32,37). Therefore, Mac-I might be required for phagocyte recognition of fibrinogen-bearing foreign bodies and biomaterial implants. This was recently tested using CD1 lb knockout (KO) and CD18 KO mice. Compared with congenic normal controls, both CD1 lb KO and CD18 KO mice failed to accumulate phagocytes on implant surfaces, although the influx of phagocytes into the implant-bearing peritoneum was unaffected.
Adding a bit more complexity to the situation is the well-established finding that resting, unstimulated phagocytes express only low levels of Mac-i (45) (and, in fact, do not preferentially adhere to albumin-coated vs fibrinogen-coated surfaces in in vitro adherence assays; W. W. Jiang, L. Tang, unpublished results). The explanation may be that Mac-I is up-regulated by cytokines such as tumor necrosis factor a (TNF-a) (46) (47) (48) as the incoming phagocytes travel toward the implant surfaces. Indeed, not only is TNF-a released in relatively large amounts following the placement of intraperitoneal implants in mice, but administration of a neutralizing antibody to TNF-a greatly decreases the numbers of phagocytes that ultimately become adherent to the implant (38, 44) .
So, the overall sequence of events in biomaterial-mediated inflammatory responses (and probably in at least some types of other foreignbody reactions) appears to be as follows: (1) (66, 67) , indicating an unusual degree of hydration and elongation (68) . The flexible, elongate shape of solution-phase fibrinogen also is supported by data from hydrodynamic measurements of model particles (69) , low-angle X-ray scattering (70) , neutron small-angle scattering (71) , and fluorescence polarization (72) . Within soluble fibrinogen, the fibrinogen D domain, which resides on both ends of the molecule, is highly folded and stacked with a-helices (73) . Probably because of this highly folded configuration, the D domain is susceptible to conformational changes and denaturation caused by thrombin-catalyzed conversion to fibrin (74) , minor environmental changes such as elevated temperature (74) , or contact with hydrophobic surfaces (43) . In the present instance, interactions between a hydrophobic foreign body and fibrinogen are likely to unfold the D domain, leading to the exposure of hidden proinflammatory epitopes, such as P1 and P2 (W.-H. Hu, T. P. Ugarova, E. P. Plow, J. W. Eaton, L. Tang, unpublished results).
Similar changes in state, with selective denaturation of the D domain, also occur upon the conversion of soluble fibrinogen to the insoluble fibrin clot (74) . These state changes also are accompanied by the exposure of previously occult epitopes such as P1 and P2 (W.-H. Hu, T. P. Ugarova, E. P. Plow, J. W. Eaton, L. Tang, unpublished results). Therefore, the inflammatory reactions to biomaterial implants may actually recapitulate natural responses to hemorrhage and coagulation. In this latter circumstance, the homeostatic responses of greatest importance are increased phagocyte vigilance (enabling the search for, and destruction of, possible invading microorganisms) and the ultimate dissolution of the clot, promoted in part by the accumulated phagocytes (75) . Ironically, in choosing hydrophobic polymers as base materials for medical devices, we may have inadvertently set off a cascade of responses meant for an entirely different purpose. It is not until we fully understand the genesis of these responses that we will be able to design more biocompatible materials and finally satisfy the dictum advanced by Robert Hooke:
The truth is, the science of Nature has been already too long made only a work of the brain and the fancy: It is now high time that it should return to the plainness and soundness of observations on material and obvious things (76 
